Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maresha Ramakrishna

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Molecular Biology Reports|May 5, 2026
Oncogenic MAGEA4 directs neuroendocrine differentiation and survival in prostate cancer cells through the SIRT1/Acetyl-p53/BCL-2 axisMaresha Ramakrishna, Teja Nallavolu, Ramesh Ummanni
The Prostate|April 18, 2023
MicroRNA-147b induces neuroendocrine differentiation of prostate cancer cells by targeting ribosomal protein RPS15ASirisha Natani, Maresha Ramakrishna, Teja Nallavolu, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2026
New thiazole-biaryls as small molecule immunomodulators (SMIs) targeting PD-1/PD-L1 axisSwapnanjali Karamtoth, Maresha Ramakrishna, Swapnil Anil Sule, et al.
The FEBS Journal|December 2, 2021
Downregulation of BORIS/CTCFL leads to ROS-dependent cellular senescence and drug sensitivity in MYCN-amplified neuroblastomaGarikapati Koteswara Rao, Venkata Krishna Kanth Makani, Jolly Janette Mendonza, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Molecular Biology Reports|May 5, 2026
Oncogenic MAGEA4 directs neuroendocrine differentiation and survival in prostate cancer cells through the SIRT1/Acetyl-p53/BCL-2 axisMaresha Ramakrishna, Teja Nallavolu, Ramesh Ummanni
The Prostate|April 18, 2023
MicroRNA-147b induces neuroendocrine differentiation of prostate cancer cells by targeting ribosomal protein RPS15ASirisha Natani, Maresha Ramakrishna, Teja Nallavolu, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2026
New thiazole-biaryls as small molecule immunomodulators (SMIs) targeting PD-1/PD-L1 axisSwapnanjali Karamtoth, Maresha Ramakrishna, Swapnil Anil Sule, et al.
The FEBS Journal|December 2, 2021
Downregulation of BORIS/CTCFL leads to ROS-dependent cellular senescence and drug sensitivity in MYCN-amplified neuroblastomaGarikapati Koteswara Rao, Venkata Krishna Kanth Makani, Jolly Janette Mendonza, et al.
Pageof 1